Editorial: Innovative value-based medicine: lessons from China's and APAC's healthcare evolution, volume II
Jing Yuan, Xiangxiang Jiang, Gang Lv, Z. Kevin Lu · 2026
Read Editorial: Innovative value-based medicine: lessons from China's and APAC's healthcare evolution, volume II by Jing Yuan, Xiangxiang Jiang, Gang Lv, Z. Kevin Lu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13651466.txt.
Description
Jing Yuan and three colleagues introduce a second collected volume on value-based medicine in China and the Asia-Pacific region, where systems are being asked to prove outcomes rather than count activity. Aging populations, chronic disease, pricey technology, and coverage promises converge faster than almost anywhere else.
The editorial threads the volume's studies through payment reform. Paying for curative effect in traditional Chinese medicine cut costs and stays for some diseases while reviving traditional services. A bundled payment scheme for diabetes lowered hospital costs yet shifted out-of-pocket burden onto certain insured groups and hospital types. High-margin cases under bundled payment tended to be low-value stays, suggesting waste can move rather than vanish. Single-disease payment for hysterectomy cut costs and complications together. The editors argue value emerges from many instruments at once, and that reforms watched only in aggregate can hide new inequities.
Catalog record
| CREATOR | Jing Yuan, Xiangxiang Jiang, Gang Lv, Z. Kevin Lu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 7 KB |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |